跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
氯替泼诺混悬滴眼液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Loteprednol Etabonate Ophthalmic Suspension
Approved
化学药品
Loteprednol Etabonate Ophthalmic Suspension
Bausch & Lomb Incorporated
🇨🇳 National Medical Products Administration
Approval Date
May 11, 2023
Approval ID
1yQCLjDxU80
Company
Bausch & Lomb Incorporated
Type
化学药品
Approval Details
Approval Id
1yQCLjDxU80
Approval Number
国药准字HJ20191002
Generic Name
氯替泼诺混悬滴眼液
Generic Name En
Loteprednol Etabonate Ophthalmic Suspension
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
0.2%(5ml:10mg;10ml:20mg)
Reg Date
2023-05-11
Expired Date
2028-03-28
Company Name
Bausch & Lomb Incorporated
Production Company Name
Bausch & Lomb Incorporated
Company Detail Path
/organization/bausch-and-lomb-incorporated
Production Company Detail Path
/organization/bausch-and-lomb-incorporated
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 11, 2023
Approval ID
1yQCLjDxU80
Type
化学药品
Back to NMPA Approvals
